|
Spanish / Español
Individuals
with degenerated discs in the lower (lumbar) spine sometimes
suffer from disabling, chronic low back pain. Most patients
with symptomatic degenerative conditions in the spine are
treated non-surgically with anti-inflammatory medications,
physical therapy and injections. Most of these individuals
will favorably respond to non-surgical methods of treatment,
but a subset of individuals will continue to experience
pain. The chronic nature of back pain often interferes with
the ability to work and participate in regular daily activities.
As a result, surgical treatment may become necessary.
There
are multiple conservative and minimally invasive treatment
options available to manage symptomatic degenerative disc
disease. However, if surgery is indicated the surgical treatment
of choice has traditionally consisted of a lumbar spinal
fusion. Unfortunately, there are a number of drawbacks to
undergoing a spinal fusion. First, the ability of the bone
to heal or “fuse” varies. The average success rate of a
lumbar spinal fusion is approximately 75%-80%. Failure of
the fusion to heal may be associated with continued symptoms.
Second, a spinal fusion at one or more levels will cause
stiffness and decreased motion of the spine. Third, having
a spinal fusion at one or more levels will cause more stress
to be transferred to adjacent levels. The problem with the
transferred stress is that it may cause new problems to
develop at the other levels, which may also lead to additional
back surgery.
For
these reasons, neurosurgeons and orthopedic surgeons have
engaged in research to offer an alternative to lumbar spinal
fusion surgery. One promising area of research includes
the development of an artificial spinal disc. In order to
better appreciate the advantages and disadvantages of artificial
spinal disc replacement, it is important to have a basic
understanding of normal spinal anatomy, including the function
of the spinal discs.
The
spine is a column that is made of up bones and discs. The
blocks of bone (or vertebrae) provide the anterior support
and structure of the spine. Posteriorly, the two facet joints
at each level provide stability and movement of the motion
segment. The spinal discs are in between the bones and act
like a cushion or “shock absorber” between the vertebrae.
The discs also contribute to the flexibility and motion
of the spinal column. The discs are made up of two parts:
1) the inner portion of the disc is called the nucleus pulposus
and is a jelly-like material 2) the outer part of the disc
is a stronger, more fibrous, material called the annulus
fibrosus. The annulus fibrosus surrounds and supports the
inner jelly material. The annulus is also in contact with
nerve fibers or pain receptors, called nociceptors. Disc
material is primarily composed of water and other proteins.
As a normal part of aging, the water content gradually diminishes
which can cause the disc to flatten out and even develop
tears or cracks throughout the annulus fibrosus. These discs
are often referred to as “degenerative”discs and may or
may not cause pain.
In
the case of a degenerative disc, the inner jelly material
can bulge out and press up against the annulus fibrosus.
This can stimulate the pain receptors causing back pain
to occur. The cracks or tears that develop within the annulus
fibrosus can also become a source of pain. Back pain that
is caused by the spinal disc is often referred to as discogenic
low back pain.
Sir
John Charley revolutionized orthopedics in the 1960’s with
the advent of the total hip replacement. At that time, early
research in the development of artificial disc replacement
began as well. Despite the early interest, lumbar spinal
fusion remained the gold standard treatment for back pain.
Because of the complications associated with lumbar spinal
fusion, a renewed interest in artificial disc replacement
resurfaced in the 1990’s. The purpose and advantage of artificial
disc replacement is to replace the worn out disc, while
preserving the motion at the operated spinal level. This
could potentially not only treat the underlying back pain,
but also protect patients from developing problems at an
adjacent level of the spine.
 Figure 1. CHARITÉ™ Artificial Disc (DePuy Spine, Inc.) Photograph Courtesy of DePuy Spine, Inc.
 Figure 2.
The Food and Drug Administration (FDA) has approved the CHARITÉ™ Artificial Disc (DePuy Spine, Inc. of Raynham, MA) for use in treating pain associated with
degenerative disc disease. The device was approved for use at one level in the
lumbar spine (from L4-S1) for patients who have had no relief from low back pain
after at least six months of non-surgical treatment.
Currently,
artificial disc replacement is considered experimental and
is not approved by the Food and Drug Administration (FDA).
Most of the research that has been conducted on artificial
discs has been carried out in Europe. Different models have
been developed, but the most widely used and known artificial
disc is the LINK SB Charite III prosthesis made by Waldemar
Link GmbH & Company, Hamburg, Germany. The model consists
of two metal metallic plates that have teeth to anchor the
implant between the bones or vertebral bodies. Between the
two plates is a rubber core made up of polyethylene that
allows for motion (See Figure 1). A metal ring surrounds
the outside of the rubber core so that it can be located
on x-ray (See Figure 2).
In
order to avoid complications that may arise from artificial
disc replacement surgery, careful selection of patients
by the surgeon is critical. At present, it is thought that
the best candidates for spinal disc replacement are adults
with a one level symptomatic degenerative disc. Patients
whose bone may not be as strong due to aging, or some other
bone disorder, may develop problems if the implant settles
into the “soft” bone. Therefore, these individuals are not
considered optimal candidates for this type of procedure.
Since there can be movement of the implant, patients with
a slippage of one vertebra on another (termed “spondylolisthesis”)
are also not considered candidates for artificial disc replacement.
Based on the current research, the clinical diagnoses that
seem the most fitting for artificial disc replacement include
symptomatic degenerative disc disease and post-discectomy
syndrome. Post-discectomy syndrome is persistent back pain
following previous surgery to remove a herniated disc.
In
addition to the potential complications associated with
undergoing surgery and general anesthesia, the complications
associated with artificial disc replacement may include
breakage of the metal plate, dislocation of the implant,
and infection. To help minimize complications associated
with the implant itself, proper selection of patients and
size of implant is very important. Patients may also not
improve following the procedure and may require additional
surgery. Finally, like joint replacement surgery, artificial
implants may fail over time due to wear of the materials
and loosening of the implants. Therefore, long term studies
that track the life span of the implants are needed.
Another
artificial disc device that is similar to the metal implant
is the prosthetic disc nucleus (PDN). Like the metal implant,
the purpose of it is to restore disc height and allow for
normal spinal motion. However, instead of the whole disc
being removed, with the prosthetic disc nucleus, only the
inner jelly material, or nucleus, is removed and is then
replaced with two mini “pillows” (See Figure 3).
|